机器人辅助康复治疗乳腺癌继发上肢淋巴水肿患者:一项随访6个月的随机对照试验方案
本研究为随机、平行组、优效性对照试验方案,拟纳入44例乳腺癌继发上肢淋巴水肿患者,随机分入机器人辅助康复组或常规康复组,两组均每周3次、持续10周个体化训练,主要结局为淋巴水肿生活质量问卷,评估于训练前、训练后及6个月后,并进一步分析合并颌骨转移者的效果。
要点
- 机器人辅助康复组与常规康复组均每周3次、持续10周个体化训练。
- 主要结局为淋巴水肿生活质量问卷,次要结局为疼痛数字评分量表和颅面疼痛残疾量表。
- 评估时点为训练前、训练后及6个月后。
核心结论
- 研究结果可能为机器人辅助康复项目改善乳腺癌继发上肢淋巴水肿患者健康相关生活质量和疼痛提供证据。
- 乳腺癌合并颌骨转移且发生上肢淋巴水肿者,预期可获得与上述比较相似或更高的改善。
- 该试验可能有助于界定良好临床康复常规的指南,并可能作为卫生主管部门认可的依据。
研究设计与样本
- 随机、平行组、优效性对照试验。
- 拟纳入44名参与者,随机分配至实验组(接受机器人辅助康复项目)或对照组(常规康复)。
- 两组均遵循个体化方案,每周3次,持续10周。
- 评估时点为训练前、训练后及6个月后。
- 试验注册于OSF REGISTRIES,注册号osf-registrations-jz7ax-v1,注册日期2023年6月26日。
关键数值与推荐
- 主要结局指标为淋巴水肿生活质量问卷。
- 次要结局指标为疼痛强度数字评分量表和颅面疼痛残疾量表。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Upper limb lymphedema (ULLy) is an external (and/or internal) manifestation of lymphatic system insufficiency and deranged lymph transport for more than 3 months and frequently affects people as a consequence of breast cancer (BC). ULLy is often underestimated despite diminished motor skills, mood, and cognitive-behavioral complaints negatively condition the health-related quality of life (HRQoL) of persons. BC can also metastasize to the jawbone, further impacting on the HRQoL. In time, the implementation of robot-assisted rehabilitation (RR) for neurological diseases has grown to improve HRQoL and pain. This study aims to evaluate the effectiveness of a RR program in the treatment of individuals who develop an ULLy; as a further analysis, the study will assess the effectiveness of the same program in people with jawbone metastases from BC who will also develop ULLy. A randomized, parallel-group superiority-controlled trial will be conducted. 44 participants will be randomly allocated to either the experimental (receiving a RR program) or the control group (regular rehabilitation). Both groups will follow individual-based programs three times a week for 10 weeks. The main outcome measure will be the Lymphedema Quality of Life Questionnaire. Secondary outcomes will be a pain intensity numerical rating scale and the Cranio-Facial Pain Disability Inventory. Evaluations are before and after training and 6 months later. Findings may provide evidence on the effectiveness of a RR program on inducing improvements in the HRQoL and pain of individuals with ULLy due to BC. People with ULLy and jawbone metastases from BC are expected for similar or higher improvements as per the same comparisons above. This trial might contribute towards defining guidelines for good clinical rehabilitation routines and might be used as a basis for health authorities' endorsements.Trial registration OSF REGISTRIES, osf-registrations-jz7ax-v1 . Registered on 26 June 2023.
引用
- Arippa F, Scribante A, Rocca B, et al. Robot-assisted rehabilitation of people with breast cancer developing upper limb lymphedema: protocol of a randomized controlled trial with a 6-month follow‑up. Trials. 2023. PMID: 37964287. doi:10.1186/s13063-023-07778-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。